BETA-THALASSEMIA MUTATIONS IN PUNJAB, PAKISTAN (2016- 2022), HIGHLIGHTING RARE VARIANTS DURING COVID-19 (2019- 2020)
BMC Journal of Medical Sciences · 29.06.2026 · 7 (1) · 75-81
DOI: 10.70905/bmcj.07.01.0640 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Journal of Medical Sciences, online erschienen am 29.06.2026. Verfasst von Shahida Parveen und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Beta-thalassemia is one of the most common inherited hemoglobin disorders in Pakistan, with a heterogeneous mutation spectrum that varies across different geographic regions, making region-specific mutation data essential for accurate prenatal diagnosis and genetic counseling.
Objective
This study evaluated the frequency, regional diversity, and rare beta-thalassemia mutations in Punjab, Pakistan, during 2016–2022, emphasizing implications for prenatal diagnosis, genetic counseling, and possible COVID-19-related temporal variations. Material and Methods: A retrospective study was performed from 2016–2022 at Nishtar Hospital Multan. Chorionic villus samples from 1000 pregnant women with gestational ages of 12–14 weeks undergoing prenatal diagnosis for beta-thalassemia were collected along with parental blood samples. Samples were analyzed at the Punjab Thalassemia and Other Genetic Disorders Prevention and Research Institute, Lahore, for 17 beta-thalassemia mutations using PCR-based molecular techniques. Genomic DNA extraction and beta-globin gene amplification were performed. Descriptive statistics and chi-square analysis were applied to compare mutation frequencies across years and demographic groups.
Results
IVS 1-5 (G-C) was the most prevalent mutation (39.06%), followed by Fr 8-9 (+G) (30.94%) and Cd-15 (G-A) (6.6%). Rare mutations included IVS1-1 (G-T) (2.8%), Exon mutation (1.1%), and Cap+1 (A-C) (0.8%). Rare variants including HbS, HbD, Cd-16, and Exon mutations appeared intermittently during 2016–2020. Exon mutation frequency increased during late 2019–2020, coinciding temporally with the COVID-19 pandemic period; however, no causal association could be established. Mutations were most common in women aged 25–29 years and gravida three or more.
Conclusion
The study revealed significant regional variation in common and rare beta-thalassemia mutations in South Punjab, supporting improved prenatal diagnosis, targeted mutation screening, and genetic counseling, while further multicenter studies are needed to explore possible COVID-19-related associations.
Zitieren
APA
Parveen, S., Aziz, A., Ehsan, Y., Warraich, D., & Mehmood, R. (2026). BETA-THALASSEMIA MUTATIONS IN PUNJAB, PAKISTAN (2016- 2022), HIGHLIGHTING RARE VARIANTS DURING COVID-19 (2019- 2020). BMC Journal of Medical Sciences, 7(1), 75-81. https://doi.org/10.70905/bmcj.07.01.0640
Vancouver
Parveen S, Aziz A, Ehsan Y, Warraich D, Mehmood R. BETA-THALASSEMIA MUTATIONS IN PUNJAB, PAKISTAN (2016- 2022), HIGHLIGHTING RARE VARIANTS DURING COVID-19 (2019- 2020). BMC Journal of Medical Sciences. 2026;7(1):75-81. doi:10.70905/bmcj.07.01.0640
BibTeX
@article{Parveen2026,
author = {Parveen, Shahida and Aziz, Amna and Ehsan, Yasmeen and Warraich, Daniyal and Mehmood, Rubaida},
title = {BETA-THALASSEMIA MUTATIONS IN PUNJAB, PAKISTAN (2016- 2022), HIGHLIGHTING RARE VARIANTS DURING COVID-19 (2019- 2020)},
journal = {BMC Journal of Medical Sciences},
year = {2026},
volume = {7},
number = {1},
pages = {75--81},
doi = {10.70905/bmcj.07.01.0640}
}
EUVIMED